GLDB yields 0.20% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, GLDB + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GLDB + PFE for your $10,000?
GLDB combines traditional and digital value stores under one strategy, balancing exposure between Bitcoin (BTC) and gold. This combines the growth potential of digital assets with the stability of precious metals. The fund uses a quantitative allocation framework and begins with a 50/50 weekly weighting, adjusting based on volatility, momentum, and proprietary risk metrics. Holdings can shift up to 100% toward either asset if conditions warrant. As part of the strategy, the fund employs 1.25x leveraged exposure through derivatives such as futures, options, swaps, as well as ETPs holding BTC, gold, and related assets. The fund may also hold assets like Ether (ETH) and silver. The fund gains up to 25% of its exposure through a Cayman Islands Subsidiary, thus avoiding K-1 forms. Remaining assets are held in US treasuries, cash, and short-term instruments as collateral.
Full GLDB Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.